PA-PMI
24.3.2021 16:32:07 CET | Business Wire | Press release
Project Management Institute (PMI), the world's leading association for project professionals and changemakers, today released its annual Pulse of the Profession® report. Although organizations went through major disruption in the past year, and many projects were put on hold, the report found that organizations were able to rise to the challenge. In fact, of those projects that did forge ahead, 73 percent met original goals and business intent compared to 69 percent last year. 62 percent were completed within budget, and 55 percent on time, compared to 59 percent and 53 percent respectively in last year’s report. As a result, wasted investment due to poor project performance declined to 9.4 percent versus 11.4 percent in last year's survey.
Respondents were asked to characterize their organization’s approach to ways of working, and nearly a third (32 percent) said that any and all possible methods were primarily or exclusively used to solve problems. This is a characteristic of a "gymnastic enterprise.” As outlined in the research, gymnastic enterprises are leading organizations who are able to thrive because they focus on outcomes rather than process, with a clear sense of how to balance structure and governance while embracing change. They empower their people to make change happen by enabling them to master different ways of working, to become well-rounded professionals, and to elevate their power skills. Conversely, 30 percent of respondents shared that their organizations primarily or exclusively consider using methods that have proven effective for them in the past. This is a characteristic of a traditional enterprise. The enduring problem that these traditional enterprises face today is that their structures and ways of working remain very rigid in the midst of change.
“Our 2021 Pulse of the Profession research shows how gymnastic enterprises are thriving in The Project Economy by tailoring their ways of working and empowering their people to lead as changemakers,” said Mike DePrisco, Chief Operating Officer of PMI. “By enabling employees to work smarter, elevating power skills, and building business acumen, gymnastic organizations are delivering financial and societal value regardless of the challenges placed before them.”
The report demonstrates how gymnastic enterprises were able to reap success and nimbly shift when compared to traditional enterprises. For example, gymnastic enterprises were more likely to have high levels of organizational agility (48 percent versus 27 percent) combined with frequent use standardized risk management practices (68 percent versus 64 percent). They were able to adapt faster to the pandemic, being far more likely to have undergone business change in 2020. And, they were much more likely to have seen increased productivity (71 percent versus 53 percent) and better project outcomes in 2020—in turn resulting in less wasted investment (9 percent versus 10.5 percent).
Gymnastic enterprises are also using technology to augment human skills and help their people continuously improve, prioritizing the enterprise-wide adoption of complex problem-solving techniques (47 percent versus 35 percent); AI-driven tools (39 percent versus 30 percent); on-demand, microlearning apps (39 percent versus 30 percent); and career assessment tools (37 percent versus 30 percent). With their focus on augmenting human skills, and on creative collaboration, it’s no surprise that gymnastic enterprises put the highest priority on power skills—especially collaborative leadership (54 percent versus 42 percent of traditional enterprises).
By enabling their people to become changemakers, gymnastic enterprises are better able to sense and respond to shocks, drive change, and face the future, knowing that they have the mindset, skills, and tools that it takes to win. These findings attest to just how important it is for organizations to adopt these approaches.
A total of 3,950 project professionals representing a range of industries and regions, including North America, Europe, Asia Pacific, Sub-Saharan Africa, Latin America, South Asia, Middle East/North Africa, and China were surveyed for the report. The survey was also supplemented by in-depth interviews spanning a wide range of industries and regions.
To read more about how gymnastic enterprises are turning ideas into reality, view the full report here .
About Project Management Institute
Project Management Institute (PMI) is the world's leading professional association for a growing global community of millions of project professionals and changemakers worldwide.
As the world’s leading authority on project management, PMI empowers people to make ideas a reality. Through global advocacy, networking, collaboration, research, and education. PMI prepares organizations and individuals at every stage of their career journey to work smarter so they can drive success in a world of change.
Building on a proud legacy dating to 1969, PMI is a “for-purpose” organization working in nearly every country around the world to advance careers, strengthen organizational success, and enable changemakers with new skills and ways of working to maximize their impact. PMI offerings include globally-recognized standards, certifications, online courses, thought leadership, tools, digital publications, and communities.
Visit us at https://www.pmi.org/ , www.projectmanagement.com , https://www.linkedin.com/company/pminstitute , www.facebook.com/PMInstitute , and on Twitter .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210324005712/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Europe’s Largest Celebration of Irish Culture Arrives in Belfast2.8.2026 10:01:00 CEST | Press release
Fleadh Cheoil na hÉireann arrives in Belfast today (2 August), bringing eight days of traditional music, culture and celebration to the city, with organisers expecting up to 800,000 visitors over the course of the festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729147569/en/ Belfast Fleadh - Maddens Bar accordian, guitar and fiddle player (Chris Heaney) One of Europe’s largest cultural events, Fleadh Cheoil na hÉireann is taking place in Belfast for the first time, transforming the city into a vibrant stage for Irish music, dance, language and culture. More than 200 events and 180 traditional music competitions are taking place across venues, streets and neighbourhoods throughout the week-long celebration. The landmark festival showcases the very best of Irish culture, with a packed programme of All-Ireland competitions, concerts, community events and performances from both established and emerging artists. As Ir
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
